Cashu
Halia Therapeutics to Unveil Novel Inflammasome Inhibitors at BIO Investment & Growth Summit
10 days ago
Stocks
Health Care
bio
BioRad Laboratories
NYSE: BIO
+0.81 (+0.31%)
262.63
USD
At close at Mar 13, 20:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
7.09B
Dividend Yield
0.00%
P/E Ratio
9.33
EPS
-64.90
Revenue
2.57B
Avg. Volume
249.25K
About
What does BIO do?
BioRad Laboratories, headquartered in Hercules, California, develops specialty chemicals and offers products for biochemical, pharmaceutical, and life science research, employing 8,030 people. It operates in Life Science and Clinical Diagnostics segments, serving various laboratory markets.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.